VERSANT VENTURES III, LLC enters SKYE BIOSCIENCE, INC. with 501.93M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/28/2023ACC: 0001209191-23-047509
10% Owner
Since Aug 2023
501.93M
Baseline shares
0.00
Direct ownership
0 positions
130.81M
Derivative underlying
2 instruments
2
Security positions
501.93M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned2.95M
Common Stock
IndirectShares owned498.98M
Total
501.93M indirect501.93M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.95M | Indirect |
| Common Stock | 498.98M | Indirect |
| Total | 501.93M | 501.93M indirect |
Derivative Holdings2
Warrant (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
130.04M
Shares owned
N/A
Exercise price
0.0206
Expiration
—
Exercise window
—
Warrant (Right to Buy)
IndirectUnderlying security
Common Stock
Underlying shares
768.12K
Shares owned
N/A
Exercise price
0.0206
Expiration
—
Exercise window
—
Total
Underlying
130.81M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Warrant (Right to Buy) Indirect | Common Stock | 0.0206 | — | — | 130.04M | N/A |
| Warrant (Right to Buy) Indirect | Common Stock | 0.0206 | — | — | 768.12K | N/A |
| Total | 130.81M | 0.00 | ||||